Cognex head of corporate M&A sells $3.46 million in stock
#Cognex #Joerg Kuechen #insider trading #stock sale #Q4 2025 results #analyst ratings #price targets #EBITDA margin
📌 Key Takeaways
- Joerg Kuechen sold $3.46 million in Cognex stock on February 20, 2026
- Kuechen also acquired $2.25 million in stock through options and restricted stock units
- Cognex reported Q4 2025 revenue of $252 million, exceeding guidance
- Analysts upgraded Cognex with mixed price targets ranging from $52 to $70
📖 Full Retelling
Joerg Kuechen, Head of Corporate M&A at Cognex Corp (NASDAQ:CGNX), sold 61,890 shares of common stock on February 20, 2026, for approximately $3.46 million, according to a Form 4 filing with the Securities and Exchange Commission. The sales were executed at prices ranging from $55.9801 to $56.2401 per share. In a related transaction, Kuechen also acquired 70,851 shares of Cognex common stock through option exercises and restricted stock unit conversions at prices ranging from $0.0 to $39.44, totaling approximately $2.25 million. The filing further indicates that Kuechen disposed of 2,575 shares at $56.03 to cover tax obligations, totaling $144,277, and an additional 3,073 shares at the same price, totaling $172,180. This insider trading activity comes as Cognex reported strong fourth-quarter 2025 results with revenue of $252 million, surpassing management's guidance of $230-245 million and marking a 10% year-over-year increase. The company's improved performance has led to positive analyst sentiment, with HSBC upgrading Cognex to a Buy rating, citing improved margin performance and cost reduction initiatives that resulted in an adjusted EBITDA margin of 22.7%, up 420 basis points year-over-year. Following these developments, KeyBanc raised its price target to $70, maintaining an Overweight rating, while Truist Securities increased its price target to $52, keeping a Hold rating, and DA Davidson raised its target to $55 while maintaining a Neutral rating.
🏷️ Themes
Insider Trading, Corporate Finance, Market Analysis
📚 Related People & Topics
Earnings before interest, taxes, depreciation and amortization
Accounting measure of a company's profitability
Earnings before interest, taxes, depreciation, and amortization, commonly known as EBITDA ( EE-bit-dah, EB-it-dah), is a measure of a company's profitability of the operating business only, thus before any effects of indebtedness, state-mandated payments, and costs required to maintain its asset bas...
Entity Intersection Graph
Connections for Earnings before interest, taxes, depreciation and amortization:
🏢
Share repurchase
3 shared
🌐
Free cash flow
3 shared
🏢
Dividend
3 shared
🌐
Renewable energy
3 shared
🌐
Substance (chemistry)
2 shared
Original Source
try{ var _=i o; . if(!_||_&&typeof _==="object"&&_.expiry AMD stock surges 14% on Meta AI partnership deal Bitcoin slips, wipes out 50% from October record high at session low Wall Street ends higher on tech rebound ahead of State of the Union address Software stocks rebound as Anthropic partnerships ease AI disruption fears (South Africa Philippines Nigeria) Cognex head of corporate M&A sells $3.46 million in stock By Investing.com Insider Trading Published 02/25/2026, 01:47 AM Cognex head of corporate M&A sells $3.46 million in stock 0 CGNX 2.50% Joerg Kuechen, Head of Corporate M&A at Cognex Corp (NASDAQ:CGNX) , sold 61,890 shares of common stock on February 20, 2026, for approximately $3.46 million. The sales were executed at prices ranging from $55.9801 to $56.2401. According to a Form 4 filing with the Securities and Exchange Commission, Kuechen also acquired 70,851 shares of Cognex common stock through option exercises and restricted stock unit conversions at prices ranging from $0.0 to $39.44, totaling $2249993. The filing also indicates dispositions of shares to cover tax obligations. A total of 2,575 shares were disposed of at a price of $56.03, totaling $144,277, and 3,073 shares were disposed of at a price of $56.03, totaling $172,180. According to InvestingPro analysis, Cognex appears fairly valued at current levels, with 13 analysts recently revising earnings upward. For deeper insights into CGNX’s valuation and access to exclusive Pro Research Reports covering 1,400+ US stocks, visit InvestingPro . In other recent news, Cognex Corp. reported its fourth-quarter 2025 results, showing a revenue of $252 million, surpassing management’s guidance of $230-245 million and marking a 10% year-over-year increase. This performance also reflected a 9% growth excluding foreign exchange effects. HSBC upgraded Cognex to a Buy rating from Hold, citing improved margin performance and cost reduction initiatives, with an adjusted EBITDA margin of 22.7%, up 420 basis poin...
Read full article at source